Loading clinical trials...
Loading clinical trials...
Chronic Obstructive Pulmonary Disease (COPD) affects at least 750,000 Canadians and is currently the 4th leading cause of death in Canada. Almost everyone with COPD suffers from shortness of breath (d...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nova Scotia Health Authority
Collaborators
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07509606 · Chronic Obstructive Pulmonary Disease (COPD), Whole Body Vibration
NCT07451977 · Chronic Respiratory Failure, Hypoxemia, and more
NCT07082738 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07477600 · Chronic Obstructive Pulmonary Disease (COPD)
Horizon Health Network
Saint John, New Brunswick
Capital District Health Authority
Halifax, Nova Scotia
Royal University Hospital
Saskatoon, Saskatchewan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions